:::

詳目顯示

回上一頁
題名:晚期癌症病人癌因性疲憊之藥物治療
書刊名:安寧療護
作者:黃銘源陳虹汶蘇文浩賴允亮 引用關係鄒孟婷
作者(外文):Huang, Ming-yuanChen, Hong-wenSu, Wen-haoLai, Yuen-liangChou, Meng-ting
出版日期:2011
卷期:16:2
頁次:頁217-227
主題關鍵詞:癌因性疲憊藥物治療癌症Cancer-related fatiguePharmacologic treatmentCancer
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:111
癌因性疲憊是晚期癌症病人最常見的症狀之一,且對病人的生活品質影響甚鉅。導致癌因性疲憊的幾種原因包括:腫瘤本身、癌症治療的副作用、貧血、肌肉組織的代謝異常、細胞激素的失衡、內分泌疾患以及心理精神因素等。所有可逆性的原因必須被排除並被適當地治療。癌因性疲憊包括了藥物與非藥物的處置。本篇論文主要針對有臨床證據證實的藥物治療方式,包括類固醇,中樞神經興奮劑,以及黃耆萃取物,進行廣泛的文獻探討。
Cancer-related fatigue (CRF) is one of the most prevalent symptoms in patients with advanced cancers. This symptom can adversely affect patient's quality of life. There are several factors that may cause cancer-related fatigue, including cancer itself, side effects of anti-cancer treatment, anemia, abnormal soft tissue metabolism, cytokines imbalance, endocrine disorders, and psychological issues. All reversible causes should be ruled out and treated appropriately. CRF can be treated with pharmacologic and nonpharmacologic measures. This article mainly focuses on the clinical evidence-based pharmacologic treatments, including corticosteroid, central nervous stimulants, and botanically-derived extract of Astragalus membranaceus.
期刊論文
1.Irvine, D. M.、Vincent, L.、Graydom, J. E.、Bubela, N.、Thompson, L.(1994)。The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy。Cancer Nursing,17(5),367-378。  new window
其他
1.Spathis, A. ; Dhillan, R. ; Booden, D. ; Forbes, K. ; Vrotsou, K. ; Fife, K.(2009)。Modafinil for the treatment of fatigue in lung cancer: a pilot study。  new window
2.Smets, E. M. ; Garssen, B. ; Schuster-Uitterhoeve, A. L.(1993)。Fatigue in cancer patients。  new window
3.Mustian, K. M. ; Morrow, G. R. ; Carroll, J. K.(2007)。Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue。  new window
4.Glapsy, J. ; Bukowski, R. ; Stienberg, D.(1997)。Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid mlignanies during cancer chemotherapy in community oncology practice。  new window
5.Bruera, E. ; Brenneis, C. ; Michaud, M.(1988)。Muscle electrophysiology in patients with advanced breast cancer。  new window
6.Braun, I. M. ; Greenberg, D. B. ; Pirl, W. F.(2008)。Evidenced-based report on the occurrence of fatigue in long-term cancer survivors。  new window
7.Ahlberg, K. ; Ekman, T. ; Gaston-Johansson, Fannie(2003)。Assessment and management of cancer-related fatigue in adults。  new window
8.Andrykowski, M. A. ; Donovan, K. A.(2010)。Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors。  new window
9.Scott, L. V. ; Dinan, T. G.(1999)。The neuroendocrinology of chronic fatigue syndrome: Focus on the hypothalamic-pituitary-adrenal axis。  new window
10.Lee, B. N. ; Dantzer, R. ; Langeley, K.(2004)。A cytokine-based neuroimmunologic mechanism of cancer- related symptom。  new window
11.Bruera, E. ; Roca, E. ; Cedaro, L.(1985)。Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study。  new window
12.Hardy, J. R. ; Rees, E. ; Ling, J.(2001)。A prospective survey of the use of dexamethasone on a palliative care unit。  new window
13.Tannock, I. ; Gospodarowicz, M. ; Meakin, W.(1989)。Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response。  new window
14.Matsuo, N. ; Morita, T. ; Iwase, S.(2011)。Efficacy and undesirable effects of corticosteroid therapy experienced by palliative care specialists in Japan: A nationwide survey。  new window
15.National Comprehensive Cancer Network(2012)。Inc: Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue。  new window
16.Mulhern, R. K. ; Khan, R. B. ; Kaplan, S.(2004)。Short-term efficacy of methylphenidate: A randomized, double-blind, placebo controlled trial among survivors of childhood cancer。  new window
17.Bruera, E. ; Driver, L. ; Barnes, E. A.(2003)。Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report。  new window
18.Lower, E. E. ; Fleishman, S. ; Cooper, A.(2009)。Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: A randomized clinical trial。  new window
19.Moraska, Amanda R. ; Sood, Amit ; Dakhil, Shaker R.(2010)。Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial。  new window
20.Sugawara, Y. ; Akechi, T. ; Shima, Y.(2002)。Efficacy of methylphenidate for fatigue in advanced cancer patients:A preliminary study。  new window
21.Pascal, J. ; Gray, R. ; Joseph, A.(2010)。A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy。  new window
22.Chen, H. W. ; Lin, I. H. ; Chen, Y. J.(2012)。A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: A phase II double-blind, randomized placebo-controlled study。  new window
23.Guo, L. ; Bai, S. P. ; Zhao, L. ; Wang, X. H.(20110918)。Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival。  new window
24.Jager, A. ; Sleijfer, S. ; van der Rijt, C. C.(2008)。The pathogenesis of cancer related fatigue: Could increased activity of pro- inflammatory cytokines be the common denominator?。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top